Back to Trades
Total Value
$253.8K
Filing Date
Sep 30, 2025
1 transactions
Trade Summary
On Sep 26, 2025, Chu Yu-Waye, Insider, reported $253.8K of CytomX Therapeutics, Inc. (CTMX) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $2.90. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- CytomX Therapeutics, Inc.
- Ticker Symbol
- CTMX
- CIK
- 0001501989
Insider Information
- Name
- Chu Yu-Waye
- Role
- Insider
- Location
- SOUTH SAN FRANCISCO, CA
Filing Details
- Filing Date
- Sep 30, 2025
- Transaction Date
- Sep 26, 2025
- Accession Number
- 0001610717-25-000356
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Sep 26, 2025 | CTMX derivative | 87,500 | $2.90 | Grant/Award | $253.8K |
| Sep 26, 2025 | CTMX derivative | 43,750 | — | Grant/Award | — |
Want live alerts when Chu Yu-Waye trades again?
Download Insider Trades to track CTMX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)1/48th of the shares subject to the option vest on each monthly anniversary measured from September 26, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.
- (F2)Each Performance Stock Unit ("PSU") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/3 of the PSUs vest upon the achievement of each of three clinical milestones, subject to the Reporting Person continuing as a service provider through each such date.